Stay updated on RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown, replacing the previous Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-11T12:31:01.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The change is a minor site version update, replacing Revision: v3.4.0 with Revision: v3.4.1, with no impact on study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T07:36:16.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page adds a glossary toggle and updates metadata labels and revision information (showing 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and revision to v3.4.0), while removing the previous entries and older revision (Last Update Submitted that met QC Criteria, 'No FEAR Act data', and v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T05:48:53.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T01:29:23.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations sections were added, listing participating sites across multiple regions and countries (California, Colorado, Connecticut, Massachusetts, New York, North Carolina, South Carolina, Tennessee, Texas, Ontario, Campania, Tuscany, Navarre). The header shows a new Revision: v3.3.3 and the HHS Vulnerability Disclosure footer link was removed.
    Difference
    1%
    Check dated 2025-12-23T10:30:33.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The Publications section description was updated to indicate that PubMed-listed publications are automatically filled and may not be about the study, and that the revision tag has changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:55:58.000Z thumbnail image

Stay in the know with updates to RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RO6958688 Combination with Atezolizumab in CEA+ Solid Tumors Clinical Trial page.